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I spoke at NABC 5, when the title of my talk was The Papaya Story: A Special Case or a 
Generic Approach? In the mid-980s when we developed the transgenic approach, Roger 
Beachy and I were at the epitome of intellectual excitement. We believed that, in 0 years, 
the major crops would be improved through genetic engineering. The technology that 
led to the development of virus-resistant papaya is beautiful, and yet when I end my talks 
these days, I ask, “Really, what has happened over the past 5 years?” If we don’t address 
that question seriously, I’ll guarantee you that in 0 years or even 5 years from now we 
will be asking, “What happened?” At the end of my talk, we’ll see whether my transgenic 
papaya story is a public-sector anomaly, or whether that approach is widespread.
Figure  shows a beautiful, delicious Hawaiian papaya. Roger Beachy and I became 
virologists because we wanted to fight virus diseases. Figure  shows the symptoms of 
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Figure . Virus-free papaya in Hawaii.
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papaya ring-spot virus (PRSV), which has been in Hawaii since 945. No natural resistance 
exists, and it is spread rapidly by insects. 
Advance of PRSV
In 978, the dean of the College of Agriculture pointed out to me that the virus—having 
destroyed the papaya industry in Oahu—had been identified in Hilo, just 9 miles from 
Puna where 95% of Hawaii’s papaya’s was grown (Figure 3).
Figure . Papaya infected with ring-spot virus.
Figure 3. The potential problem.
2Pages 9–8.
He suggested that I do some research to try to develop a means of control. So, way back 
then, in 978, we started by working up a rapid detection method, and then developed 
the pathogen-derived resistance method that Roger Beachy talked about2. Basically, by 
the mid-980s the concept (Figure 4) had been proven with virus-resistant tomato.
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Figure 5. 988–89, Maureen Fitch using the gene gun to transform papaya.
Figure 4. Pathogen-derived resistance.
We decided to take the coat-protein gene of the virus and place it in the chromosome 
of the papaya, in the hope that it would induce resistance, although, back then, in 984 
when we started, DNA sequencing was difficult as was cloning. And the dogma at that 
time was that resistance was coat-protein mediated, whereas our papaya ringspot had no 
natural start signal. So we actually added some amino acids from the cucumber mosaic 
virus to achieve a start signal.
I was fortunate in being at Cornell’s Geneva Experiment Station, where John Sanford 
and his colleague had invented the gene gun. With Jerry Slightom, an excellent molecular 
biologist, and graduate student Maureen Fitch, we cloned the coat-protein gene in 984, 
and Figure 5 shows the “father” of the gene gun in 988. We were still using .-caliber 
blanks to shoot in genes.
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First Virus-Resistant Papaya
Figure 6 shows a picture—taken at Cornell University in April 99—of transgenic papaya 
line 55-, which was a non-transgenic ‘Sunset’ transformed with the coat-protein gene 
inoculated with virus; the plant on the left contained the viral coat protein. This is where 
our group philosophy differed from the conventional wisdom of finding out if progeny 
indicated single-gene resistance. Instead, we cloned plants from tissue-culture, put them 
in the field and, within a year, our first trial was in progress.
Figure 6. 99: Virus-infected papaya, genetically engineered plant on left.
By April 99, cloned plants of this line were in the field in Oahu to see if resistance 
occurred. The long-awaited presence of the virus in Puna was reported in May 99. 
Figure 7 shows devastation that occurred in 994.
4
Having proven the concept, Richard Mashardt backcrossed the female line 55- with 
the non-transgenic sibling Sunset until line 55- was homozygous for the coat-protein 
gene; he called this cultivar ‘SunUp.’ Growers wanted yellow flesh, so he made an F 
hybrid of ‘SunUp’ and non-transgenic ‘Kapoho’ to come up with transgenic ‘Rainbow’ 
Figure 7. Puna: 994.
Figure 8. Transgenic ‘Rainbow’ surrounded by non-transgenic papaya.
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papaya. He utilized the field of less than an acre at the Waimanalo Experiment Station 
on Oahu to develop all this within three years of our first field test in May 99.
Figure 8 shows a solid block of transgenic ‘Rainbow’ surrounded by a non-transgenic 
line in a field trial in Kapoho. There was no question that the transgenic approach was 
working, and growers saw it and requested it. We told them that they could not have it 
until after deregulation. But who would finance the deregulation of a public-sector proj-
ect? John Sanford and I applied for an NSF grant, without success. The team’s first grant 
for the papaya work was for about $5,000.00 for three years—special funds through 
Senator Inouye—it was no million dollars.
Red Zone and Release
So, we scientists entered the “red zone” (Figure 9). I had never done any regulatory work, 
but it was necessary if we were to help the growers. Back then it was easier than it is 
today; the process is represented in Figure 0. I recall a meeting when growers suggested 
that the technology would be too expensive for their adoption because Monsanto would 
likely charge $0 million. They had read that in the newspaper. Within a year, the Papaya 
Administrative Committee (PAC) had the license, and Monsanto did not charge a dime 
for it, showing that it’s a mistake to rationalize yourself out of doing something.
In May of 998, almost 6 years to the day after the virus was discovered in Puna, we 
were able to release seed to growers. If we had started our research after the virus had 
reached Puna there would be no papaya industry in Hawaii today. I’m not a philosopher, 
but I would say that if, under the best circumstances, something is likely to take time, 
start on it immediately. If timing is critical, don’t wait until you have the ultimate answer. 
Use best judgment and move forward (Figure ).
Figure 9. Hawaiian transgenic papaya (995):
Entering the red zone of translational biotechnology.
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Figure 0. Deregulation and commercialization.
Figure . Under the best circumstances, it takes time.
Figure . Coexistence under an identity-preservation protocol.
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Deregulation Elsewhere
In Hawaii, we’ve been growing non-transgenic and transgenic papaya for more than a 
decade, because Japan, until recently, imported only non-transgenic papaya. This was 
achieved using identity-preservation protocols. Figure  shows a photograph taken in 
004, an example of the few fields where this applies. The most pressing problem isn’t 
gene flow, it’s loss of the non-transgenic crop due to the virus.
Deregulation in Canada was rapid because they acted on information from the 
United States. We started trying to deregulate the papaya in Japan a year after it was 
commercialized in the United States in 998; it’s a long story, but in December 0 it 
was deregulated. 
There is a common misperception that the Japanese consumer would be reluctant to 
buy it because it was labeled as being genetically modified. We went there expecting that 
with the first shipment of papaya, which was sold at Costco Japan. The most prevalent 
questions were, “How expensive is it?” and “Does it taste okay?” The Flavr Savr™ tomato 
failed not because it was genetically modified, but because it was unpopular. If you have 
a good product, consumers will buy it.
Addressing the Continuing Threat
In 00, I said, “Don’t forget the past,” and Figure 3 contrasts the papaya situation 
then with how it had been in 994. This is particularly appropriate now because a bill 
was recently introduced by a councilwoman on the big island in the county of Hawaii to 
ban all GMOs on the island of Hawaii where nearly all of the papaya is grown. The GM 
papaya would be “grandfathered” in, but would be grown under BSL-3 conditions. That 
bill was voted down. On July nd they changed the wording to require a 750-ft buffer zone 
Figure 3. Don’t forget the past.
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Figure 4. 0—transgenic papaya at 85% of production.
PRSV remains a threat.
Figure 5. 997—transgenic papaya brought to Thailand.
between transgenic and non-transgenic papaya, which farmers are unhappy about. Now 
that I’m retired and a private citizen, I say that enough is enough. Papaya is the cheapest, 
most nutritious fruit in Hawaii. Four may be purchased for only a dollar in a farmers’ 
market in Hawaii. This is the message that consumers must get across to the politicians. 
Some 85% of papaya now grown in Hawaii is transgenic. It’s reasonably priced, and it 
tastes good; it’s better than non-transgenic papaya. Figure 4 shows why farmers avoid 
non-GM genotypes: PRSV is still a serious threat.
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Thai Story: The Human Element
In 994 we were asked to help tackle PRSV in Thailand. In our lab, Thai scientists devel-
oped locally adapted transgenic genotypes, which, in 997, we hand-carried to Thailand. 
They worked beautifully in field trials. However, due to politics and lobbying of activists, 
our transgenic papaya will never be available to the Thai consumer and serious damage 
from the virus will continue to affect production and compromise the living standards 
of those who are most vulnerable (Figure 6).
In 03, is transgenic papaya still a public-sector anomaly? Absolutely. We must con-
tinue our efforts in the red zone, dealing with people and with politics. We must bring 
the human element into the picture. What will the next 5 years bring? I hope it will 
not be the same old story.
Figure 6. Keep the human element in transgenic efforts.
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